SSE STAR Earnings Quality Strategy Index and Other Indices Will Be Launched

Shanghai Stock Exchange and China Securities Index Co., Ltd announce the upcoming launch of SSE STAR Earnings Quality Strategy Index，SSE STAR Brand Name Drug Index and SSE STAR Value 50 Strategy Custom Index on August 23, 2024 to provide the market with more investment products.

SSE STAR Earnings Quality Strategy Index selects 50 securities with high profitability and abundant cash flow from STAR market as constituents. The index is to measure the performance of securities of listed companies with high earnings quality of STAR market.

SSE STAR Brand Name Drug Index selects 30 securities of listed companies with the largest market capitalization engaged in brand name drug fields as constituents. The index is to measure the performance of the representative companies in the brand name drug industry of STAR market.

SSE STAR Value 50 Strategy Custom Index selects 50 securities with lower operating risks and valuation from STAR market as constituents. The index is to measure the performance of securities of listed companies with value characteristics of STAR market.

Regarding the methodologies and more details about the above indices, please refer to the official website of Shanghai Stock Exchange (www.sse.com.cn) and CSI (www.csindex.com.cn).

Constituent List for SSE STAR Brand Name Drug Index

Constituent List for SSE STAR Earnings Quality Strategy Index

Constituent List for SSE STAR Value 50 Strategy Custom Index

Methodology of SSE STAR Brand Name Drug Index

Methodology of SSE STAR Earnings Quality Strategy Index

Methodology of SSE STAR Value 50 Strategy Custom Index

Shanghai Stock Exchange

China Securities Index Co., Ltd.

Aug 16, 2024